The US Food and Drug Administration (FDA) announced that it has issued final guidance for developers of medical mobile apps - user-friendly software programs that run on mobile communication devices, such as smartphones and tablet computers. The guidance reveals that the federal agency will focus regulation on a small subset of medical apps that present a greater risk and will exercise discretion for the majority that pose minimal risk to consumers...

More...